Gene · 4060
Papers3,622
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,622
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SYT7 (synaptotagmin 7) promotes cervical squamous cell carcinoma. | Heliyon | 2024 | 38314285 | PubTator, text mining | PubMed |
| Exploration of neuron heterogeneity in human heart failure with dilated cardiomyopathy through single-cell RNA sequencing analysis. | BMC Cardiovasc Disord | 2024 | 38310240 | PubTator, text mining | PubMed |
| Notch3 directs differentiation of brain mural cells from human pluripotent stem cell-derived neural crest. | Sci Adv | 2024 | 38306433 | PubTator, text mining | PubMed |
Quantification of crystallinity during indomethacin crystalline transformation from α- to γ-polymorphic forms and of the thermodynamic contribution to dissolution in aqueous buffer and solutions of solubilizer. | RSC Adv | 2024 | 38292264 | PubTator, text mining | PubMed |
| Rapid, economical diagnostic classification of ATRT molecular subgroup using NanoString nCounter platform. | Neurooncol Adv | 2024 | 38292239 | PubTator, text mining | PubMed |
| Proteomic analysis of the extracellular matrix of human atherosclerotic plaques shows marked changes between plaque types. | Matrix Biol Plus | 2024 | 38292008 | PubTator, text mining | PubMed |
| Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma. | Sci Rep | 2024 | 38291075 | PubTator, text mining | PubMed |
| Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab. | J Immunother Cancer | 2024 | 38290766 | PubTator, text mining | PubMed |
| RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma. | Cell Death Dis | 2024 | 38286983 | PubTator, text mining | PubMed |
| Developmental morphogens direct human induced pluripotent stem cells toward an annulus fibrosus-like cell phenotype. | JOR Spine | 2024 | 38283179 | PubTator, text mining | PubMed |
| Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients. | Nat Commun | 2024 | 38272877 | PubTator, text mining | PubMed |
| A single-cell atlas of conventional central chondrosarcoma reveals the role of endoplasmic reticulum stress in malignant transformation. | Commun Biol | 2024 | 38267611 | PubTator, text mining | PubMed |
| Point-of-care testing and antibiotics prescribing in out-of-hours general practice: a register-based study in Denmark. | BMC Prim Care | 2024 | 38262975 | PubTator, text mining | PubMed |
| How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction? | Proteomes | 2024 | 38250815 | PubTator, text mining | PubMed |
| miRNA profiling of esophageal adenocarcinoma using transcriptome analysis. | Cancer Biomark | 2024 | 38250763 | PubTator, text mining | PubMed |
| Synthesis and biological evaluation of novel 2-morpholino-4-anilinoquinoline derivatives as antitumor agents against HepG2 cell line. | RSC Adv | 2024 | 38249681 | PubTator, text mining | PubMed |
| Current Advances in Corneal Stromal Stem Cell Biology and Therapeutic Applications. | Cells | 2024 | 38247854 | PubTator, text mining | PubMed |
| PKCiota Inhibits the Ferroptosis of Esophageal Cancer Cells via Suppressing USP14-Mediated Autophagic Degradation of GPX4. | Antioxidants (Basel) | 2024 | 38247539 | PubTator, text mining | PubMed |
| Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction. | Clin Transl Med | 2024 | 38239097 | PubTator, text mining | PubMed |
| Exploring the mechanism of Celastrol in the treatment of rheumatoid arthritis based on systems pharmacology and multi-omics. | Sci Rep | 2024 | 38238321 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4060/papers?page=12